Mephyton and Fentanyl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mephyton (phytonadione) and Fentanyl (fentanyl citrate). Common drug interactions include febrile neutropenia among females and methaemoglobinaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Mephyton and Fentanyl. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Mephyton?

Mephyton has active ingredients of phytonadione. eHealthMe is studying from 1,006 Mephyton users. Check the latest studies of Mephyton.

What is Fentanyl?

Fentanyl has active ingredients of fentanyl citrate. It is often used in pain. eHealthMe is studying from 73,301 Fentanyl users. Check the latest studies of Fentanyl.



On Jul, 29, 2026

41 people who take Mephyton and Fentanyl together, and have interactions are studied.

Mephyton and Fentanyl drug interactions.

What are the common drug interactions of Mephyton and Fentanyl, by gender? *:

female:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Fistula (an abnormal connection or passageway between two)
  3. Gastrointestinal obstruction
  4. General physical health deterioration (weak health status)
  5. Gingival erythema (redness of gums)
  6. Gingival swelling (gums swelling)
  7. Granuloma (a small area of inflammation due to tissue injury)
  8. Insomnia (sleeplessness)
  9. Knee arthroplasty
  10. Localised infection (infection at the single location)

male:

  1. Methaemoglobinaemia (a disorder characterized by the presence of a higher than normal level of methemoglobin in blood)
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  4. Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
  5. Renal failure acute (rapid kidney dysfunction)
  6. Renal tubular necrosis (death of kidney tubules)
  7. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Bacterial sepsis
  10. Mucosal inflammation (infection of mucous membrane)

What are the common drug interactions of Mephyton and Fentanyl, by age (0-1 to 60+)? *:

0-1:

  1. Methaemoglobinaemia (a disorder characterized by the presence of a higher than normal level of methemoglobin in blood)
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  4. Hypoxia (low oxygen in tissues)
  5. Medical device complication

2-9:

n/a

10-19:

  1. Haematemesis (vomiting of blood)
  2. Nausea (feeling of having an urge to vomit)
  3. Vomiting
  4. Haematuria (presence of blood in urine)
  5. Oral intake reduced
  6. Renal disorder (kidney disease)
  7. Haematocrit decreased
  8. Haemoglobin decreased
  9. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  10. Respiratory rate increased (excess breathing rate/min)

20-29:

n/a

30-39:

n/a

40-49:

  1. Dyspnoea (difficult or laboured respiration)
  2. Emotional distress
  3. Facial pain
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Fistula (an abnormal connection or passageway between two)
  6. Gastrointestinal obstruction
  7. General physical health deterioration (weak health status)
  8. Gingival erythema (redness of gums)
  9. Gingival swelling (gums swelling)
  10. Granuloma (a small area of inflammation due to tissue injury)

50-59:

  1. Pulmonary embolism (blockage of the main artery of the lung)

60+:

  1. Anxiety
  2. Decreased interest
  3. Aphthous stomatitis (mouth ulcer)
  4. Depressed mood
  5. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  6. Dyspnoea (difficult or laboured respiration)
  7. Fatigue (feeling of tiredness)
  8. Haematemesis (vomiting of blood)
  9. Hot flush (sudden feelings of heat)
  10. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)

What are the existing conditions these people have? *

  1. Metastases To Bone (cancer spreads to bone): 7 people, 17.07%
  2. Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue): 5 people, 12.20%

* Approximation only. Some reports may have incomplete information.

Do you take Mephyton and Fentanyl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mephyton and Fentanyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mephyton:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fentanyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mephyton and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fentanyl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on phytonadione and fentanyl citrate (the active ingredients of Mephyton and Fentanyl, respectively), and Mephyton and Fentanyl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: